Bioethics Stock Performance
| BOTH Stock | USD 0.01 0.00 0.00% |
The firm shows a Beta (market volatility) of -1.73, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Bioethics are expected to decrease by larger amounts. On the other hand, during market turmoil, Bioethics is expected to outperform it. At this point, Bioethics has a negative expected return of -1.61%. Please make sure to confirm Bioethics' variance and kurtosis , to decide if Bioethics performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Bioethics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2026. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
| Begin Period Cash Flow | 667.00 | |
| Free Cash Flow | -27.5 K |
Bioethics |
Bioethics Relative Risk vs. Return Landscape
If you would invest 125.00 in Bioethics on November 8, 2025 and sell it today you would lose (124.49) from holding Bioethics or give up 99.59% of portfolio value over 90 days. Bioethics is currently does not generate positive expected returns and assumes 12.6482% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Bioethics, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Bioethics Target Price Odds to finish over Current Price
The tendency of Bioethics Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.01 | 90 days | 0.01 | about 64.72 |
Based on a normal probability distribution, the odds of Bioethics to move above the current price in 90 days from now is about 64.72 (This Bioethics probability density function shows the probability of Bioethics Pink Sheet to fall within a particular range of prices over 90 days) .
Bioethics Price Density |
| Price |
Predictive Modules for Bioethics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bioethics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bioethics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bioethics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Bioethics is not an exception. The market had few large corrections towards the Bioethics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bioethics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bioethics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.46 | |
β | Beta against Dow Jones | -1.73 | |
σ | Overall volatility | 0.41 | |
Ir | Information ratio | -0.13 |
Bioethics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bioethics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bioethics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Bioethics generated a negative expected return over the last 90 days | |
| Bioethics has high historical volatility and very poor performance | |
| Bioethics has some characteristics of a very speculative penny stock | |
| Bioethics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (107.18 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Bioethics currently holds about 554 in cash with (27.48 K) of positive cash flow from operations. | |
| Roughly 89.0% of the company shares are held by company insiders |
Bioethics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bioethics Pink Sheet often depends not only on the future outlook of the current and potential Bioethics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bioethics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.1 M | |
| Short Long Term Debt | 395.4 K | |
| Cash And Short Term Investments | 734.00 |
Bioethics Fundamentals Growth
Bioethics Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Bioethics, and Bioethics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bioethics Pink Sheet performance.
| Return On Asset | -56.39 | |||
| Current Valuation | 647.72 K | |||
| Shares Outstanding | 1.14 M | |||
| Price To Book | 2,021 X | |||
| EBITDA | (59.14 K) | |||
| Cash And Equivalents | 554 | |||
| Total Debt | 398.53 K | |||
| Book Value Per Share | (0.58) X | |||
| Cash Flow From Operations | (27.48 K) | |||
| Earnings Per Share | (0.09) X | |||
| Total Asset | 734 | |||
About Bioethics Performance
By evaluating Bioethics' fundamental ratios, stakeholders can gain valuable insights into Bioethics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bioethics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bioethics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
It intends to seek, investigate, and if warranted acquire an interest in a business opportunity. The company was incorporated in 1990 and is based in Ogden, Utah. Bioethics is traded on OTC Exchange in the United States.Things to note about Bioethics performance evaluation
Checking the ongoing alerts about Bioethics for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Bioethics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bioethics generated a negative expected return over the last 90 days | |
| Bioethics has high historical volatility and very poor performance | |
| Bioethics has some characteristics of a very speculative penny stock | |
| Bioethics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (107.18 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Bioethics currently holds about 554 in cash with (27.48 K) of positive cash flow from operations. | |
| Roughly 89.0% of the company shares are held by company insiders |
- Analyzing Bioethics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bioethics' stock is overvalued or undervalued compared to its peers.
- Examining Bioethics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bioethics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bioethics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bioethics' pink sheet. These opinions can provide insight into Bioethics' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bioethics Pink Sheet analysis
When running Bioethics' price analysis, check to measure Bioethics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioethics is operating at the current time. Most of Bioethics' value examination focuses on studying past and present price action to predict the probability of Bioethics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioethics' price. Additionally, you may evaluate how the addition of Bioethics to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |